Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study
E. van Meerten(Erasmus MC Cancer Institute), Ate van der Gaast(Erasmus MC), Peter D. Siersema(University Medical Center Utrecht), Karin Müller(Erasmus MC), T.C.K. Tran(Erasmus MC), W M H Eijkenboom(Erasmus MC), Hugo W. Tilanus(Amsterdam UMC Location University of Amsterdam), Herman van Dekken(Erasmus MC)
Cited by 127
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|795